Presentation TCT 2013 LAA Closure is Now Established - The Added Value of New Randomized Trials Would be Minimal! Presenter: Matthew Price October 27, 2013
Presentation TCT 2013 Palliative at Best: A Bridge to Other Definitive Therapies Presenter: Martyn Thomas October 27, 2013
Presentation TCT 2013 Emerging Technologies for CLI: Advantages to Working Together Presenter: Hiroyoshi Yokoi October 27, 2013
Presentation TCT 2013 How We Should Define "Responsiveness" to Renal Denervation Therapies Presenter: Krishna Rocha-Singh October 27, 2013
Presentation TCT 2013 Connecting the Disparate Dots: The Development of the TIPS Procedure Presenter: Barry Katzen October 27, 2013
Presentation TCT 2013 Japan-US Zilver Stent Study and Approval: Lessons Learned and Future Options Presenter: Neal Fearnot October 27, 2013
Presentation TCT 2013 Keynote Lecture: A Clinical and Entrepreneurial Vision of Japan-US Synergies and Health Technologies Presenter: Peter Fitzgerald October 27, 2013
Presentation TCT 2013 Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR Presenter: Neil Moat October 27, 2013